However, if your symptoms do not match the SG value, use a BG meter to confirm the SG value. When the SmartGuard ™ feature is active and you are no longer in Manual Mode, the pump uses an SG value, when available, to calculate a bolus amount. WARNING: Do not use SG values to make treatment decisions, including delivering a bolus, while the pump is in Manual Mode. Training is essential to ensure the safe use of the MiniMed ™ 780G system. WARNING: Do not use the MiniMed ™ 780G system until appropriate training has been received from a healthcare professional. A total daily dose of at least 8 units, but no more than 250 units, is required to operate in the SmartGuard ™ feature. WARNING: Do not use the SmartGuard ™ feature for people who require less than 8 units or more than 250 units of total daily insulin per day. Do not use the Guardian ™ 4 sensor in the abdomen or other body sites including the buttocks, due to unknown or different performance that could result in hypoglycemia or hyperglycemia. The Guardian ™ 4 sensor has been studied and is approved for use in patients ages 7 years and older and in the arm insertion site only. All therapy adjustments in manual mode should be based on measurements obtained using a blood glucose meter and not on values provided by the Guardian ™ 4 sensor. The Guardian ™ 4 sensor is not intended to be used directly to make therapy adjustments while the MiniMed ™ 780G is operating in manual mode. The Guardian ™ 4 sensor is indicated for up to seven days of continuous use. The sensor is intended for single use and requires a prescription. The Guardian ™ 4 sensor is intended for use with the MiniMed ™ 780G system and the Guardian 4 transmitter to monitor glucose levels for the management of diabetes. The system requires a prescription from a healthcare professional. The Medtronic MiniMed ™ 780G system consists of the following devices: MiniMed ™ 780G insulin pump, the Guardian ™ 4 transmitter, the Guardian ™ 4 sensor, One-press serter, the Accu-Chek ™ Guide Link blood glucose meter, and the Accu-Chek ™ Guide test strips. The MiniMed ™ 780G system includes SmartGuard ™ technology, which can be programmed to automatically adjust insulin delivery based on the continuous glucose monitoring (CGM) sensor glucose values and can suspend delivery of insulin when the sensor glucose (SG) value falls below or is predicted to fall below predefined threshold values. The MiniMed ™ 780G system is intended for continuous delivery of basal insulin at selectable rates, and the administration of insulin boluses at selectable amounts for the management of type 1 diabetes mellitus in persons seven years of age and older requiring insulin as well as for the continuous monitoring and trending of glucose levels in the fluid under the skin. Important safety information: MiniMed™ 780G system with SmartGuard™ technology with Guardian™ 4 sensor For a list of compatible devices, refer to user guide. § Samsung ® is a registered trademark of Samsung. These represent a current work-in-progress, and will likely see changes in the coming weeks before the release of Infuse 7.† iPhone ® mobile digital device is a registered trademark of Apple Inc. Starting an Infuse Pro subscription today, locks you into the best possible price for all future renewals. Note: An Infuse Pro subscription can be started from within the free Infuse 6 app. A single Infuse Pro subscription will be usable on all your devices (iPhone, iPad, Apple TV, Mac) and can be shared via Family Sharing. Infuse for macOS (as well as Infuse 7) will be a free upgrade for all those with an Infuse Pro subscription (monthly, yearly, lifetime). Infuse for macOS will make its App Store debut as part of Infuse 7 which is coming in Q1 2021. This will be available as a free download for all who sign up. We are currently planning to have the first public alpha available to test in early/mid December. ![]() ![]() Infuse for macOS will include most of the same great features found on iOS and Apple TV, including: Robust video playback, automatic organization, cloud streaming, Trakt sync, subtitle downloads, and more-all wrapped in a beautiful package that feels right at home on the Mac.Īny Mac (both Intel and M1) running Big Sur, or later. #staytunedġ1/20/20: Progress on Infuse for macOS has been moving along swiftly over the past few months, and today we’re pleased to be able to share a quick update and a few screenshots. Update 12/15/20: We are getting close to the first public alpha, and are targeting this Friday (12/18) to have the first public alpha available. ![]() Update 12/18/20: The first public alpha build is now available.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |